Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis. - Shariat SF; Savage C; Chromecki TF; Sun M; Scherr DS; Lee RK; Lughezzani G; Remzi M; Marberger MJ; Karakiewicz PI; Vickers AJ; Shariat, Shahrokh F; et al. (Cancer (0008543X), 2011)